Acura Pharmaceuticals Inc. (ACUR) |
|
0.531 -0.009 (-1.67%)
|
01-19 08:39 |
|
Open: |
0.531 |
Pre. Close: |
0.54 |
|
High:
|
0.531 |
Low:
|
0.531 |
|
Volume:
|
915 |
Market Cap:
|
35M |
|
|
|
|
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.53 - 0.534 |
0.534 - 0.537 |
|
Low:
|
0.523 - 0.527 |
0.527 - 0.53 |
|
Close:
|
0.525 - 0.531 |
0.531 - 0.536 |
|
Technical analysis |
as of: 2022-01-19 8:18:57 AM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.65 One year: 0.70 |
| Support: |
Support1: 0.49 Support2: 0.41 |
| Resistance: |
Resistance1: 0.56 Resistance2: 0.60 |
| Pivot: |
0.53 |
| Moving Average: |
MA(5): 0.53  MA(20): 0.53
MA(100): 0.54 MA(250): 0.48 |
| MACD: |
MACD(12,26): Signal(9): |
| Stochastic oscillator: |
%K(14,3): 40.00 %D(3): 40.71 |
| RSI: |
RSI(14): 49.38 |
| 52-week: |
High: 0.75 Low: 0.19 Change(%): 152.9 |
| Average Vol(K): |
3-Month: 903 10-Days: 454 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.ACUR has closed above bottom band by 49.3%. Bollinger Bands are 19.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 16 Aug 2021
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results - GlobeNewswire
Mon, 14 Jun 2021
Acura Pharmaceuticals Announces Conversion of Debt - GlobeNewswire
Fri, 28 Feb 2020
Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results - GlobeNewswire
Wed, 15 Nov 2017
ACUR Stock Forecast, Price & News (Acura Pharmaceuticals) - MarketBeat
Fri, 17 Mar 2017
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed® Products - GlobeNewswire
Mon, 10 Dec 2012
Acura Pharmaceuticals Launches Next Generation Cold Medicine To Aid In The Fight Against Meth - Pharmaceutical Online
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: MUTUAL_FUND |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. (M) |
65 |
| Shares Float (M) |
9 |
|
% Held by Insiders
|
18.56 |
|
% Held by Institutions
|
3.01 |
|
Shares Short (K)
|
90 |
|
Shares Short P. Month (K)
|
76 |
Stock Financials |
|
EPS
|
-0.029 |
|
EPS Est This Year
|
-0.460 |
|
EPS Est Next Year
|
0.370 |
|
Book Value (p.s.)
|
|
|
Profit Margin
|
-51.27 |
|
Operating Margin
|
-49.35 |
|
Return on Assets (ttm)
|
-38.4 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
-34.1 |
|
Gross Profit (p.s.)
|
0.028 |
|
Sales Per Share
|
0.035 |
|
EBITDA (p.s.)
|
-0.016 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
0 |
|
Levered Free Cash Flow (M)
|
0 |
Stock Valuations |
|
PE Ratio
|
-18.31 |
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
15.36 |
|
Price to Cash Flow
|
-87.28 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
